Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: A 3-year follow-up pilot study

1. Antonelou, M.H.
2. Georgatzakou, H.T.
3. Tzounakas, V.L.
4. Velentzas, A.D.
5. Kokkalis, A.C.
6. Kriebardis, A.G.
7. Papassideri, I.S.